Showing results (81-90 of 177) with videos related to

Sort By:
Pageof 18
Journal of Clinical Medicine|August 13, 2020
Athlete's Passport: Prevention of Infections, Inflammations, Injuries and Cardiovascular DiseasesCristina Mennitti, Mariarita Brancaccio, Luca Gentile, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 23, 2022
Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant RecipientsMaria Guarino, Ilaria Esposito, Giuseppe Portella, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|September 26, 2007
The contribution of omental adipose tissue to adipokine concentrations in patients with the metabolic syndromeGiovanni Tarantino, Roberto Lobello, Francesco Scopacasa, et al.
Multiple Sclerosis and Related Disorders|June 30, 2026
Real-world analytical and clinical evaluation of the Siemens Atellica® immunoassay for plasma neurofilament light chain in multiple sclerosisValerio Nicolella, Carmela Polito, Vincenzo Criscuolo, et al.
Endocrinology|September 10, 2005
A mouse model demonstrates a multigenic origin of congenital hypothyroidismElena Amendola, Pasquale De Luca, Paolo Emidio Macchia, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 1, 2012
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkersMatteo Ferro, Dario Bruzzese, Sisto Perdonà, et al.
Molecular and Cellular Biology|June 17, 2004
Rhes is involved in striatal functionDaniela Spano, Igor Branchi, Annamaria Rosica, et al.
Cancers|September 28, 2021
Prostate Health Index and Multiparametric MRI: Partners in Crime Fighting Overdiagnosis and Overtreatment in Prostate CancerMatteo Ferro, Felice Crocetto, Dario Bruzzese, et al.
Plos One|July 18, 2013
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/mlMatteo Ferro, Dario Bruzzese, Sisto Perdonà, et al.
Cancers|July 9, 2022
Liquid Biopsy in Prostate Cancer Management-Current Challenges and Future PerspectivesFelice Crocetto, Gianluca Russo, Erika Di Zazzo, et al.
Pageof 18